0001061983-21-000102.txt : 20210405
0001061983-21-000102.hdr.sgml : 20210405
20210405185029
ACCESSION NUMBER: 0001061983-21-000102
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210401
FILED AS OF DATE: 20210405
DATE AS OF CHANGE: 20210405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HENDERSON JOHN T
CENTRAL INDEX KEY: 0001226488
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50633
FILM NUMBER: 21807353
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CYTOKINETICS INC
CENTRAL INDEX KEY: 0001061983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943291317
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 280 EAST GRAND AVENUE
STREET 2: .
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 624-3000
MAIL ADDRESS:
STREET 1: 280 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-04-01
0
0001061983
CYTOKINETICS INC
CYTK
0001226488
HENDERSON JOHN T
280 EAST GRAND AVENUE
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2021-04-01
4
M
0
1133
8.64
A
8543
D
Common Stock
2021-04-01
4
S
0
1133
24.0
D
7410
D
Common Stock
2021-04-01
4
M
0
1100
8.64
A
8510
D
Common Stock
2021-04-01
4
S
0
1100
23.31
D
7410
D
Common Stock
2021-04-01
4
M
0
1100
8.64
A
8510
D
Common Stock
2021-04-01
4
S
0
1100
23.31
D
7410
D
Common Stock
83
I
by Spouse
Non-Qualified Stock Option (right to buy)
8.64
2021-04-01
4
M
0
1133
0.0
D
2011-06-18
2021-05-18
Common Stock
1133
2200
D
Non-Qualified Stock Option (right to buy)
8.64
2021-04-01
4
M
0
1100
0.0
D
2011-06-18
2021-05-18
Common Stock
1100
1100
D
Non-Qualified Stock Option (right to buy)
8.64
2021-04-01
4
M
0
1100
0.0
D
2011-06-18
2021-05-18
Common Stock
1100
0
D
Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 2, 2021
Amount includes 511 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.
By: Robert Wong For: John T. Henderson
2021-04-05